Recro Pharma CEO Gerri Henwood's 2019 pay jumps 90% to $4.6M

Recro Pharma reports 2019 executive compensation

By ExecPay News

Published: March 27, 2020

Recro Pharma reported fiscal year 2019 executive compensation information on March 27, 2020.
In 2019, four executives at Recro Pharma received on average a compensation package of $2.3M, a 60% increase compared to previous year.
Average pay of disclosed executives at Recro Pharma
Gerri Henwood, Chief Executive Officer, received $4.6M in total, which increased by 90% compared to 2018. 56% of Henwood's compensation, or $2.6M, was in stock awards. Henwood also received $360K in non-equity incentive plan, $1.1M in option awards, $554K in salary, as well as $38K in other compensation.
Michael Celano, Chief Operating Officer, received a compensation package of $1.7M, which increased by 43% compared to previous year. 37% of the compensation package, or $635K, was in option awards.
Ryan Lake, Chief Financial Officer, earned $1.5M in 2019, a 95% increase compared to previous year.
Ryan D. Lake, Chief Financial Officer, received $1.5M in 2019.

Related executives

Gerri Henwood

Recro Pharma

Chief Executive Officer

Michael Celano

Recro Pharma

Chief Operating Officer

Ryan Lake

Recro Pharma

Chief Financial Officer

Ryan Lake

Recro Pharma

Chief Financial Officer

You may also like

Source: SEC filing on March 27, 2020.